secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cellectar Biosciences, Inc. (CLRB)
CIK:        0001279704
Form:       8-K
Filed at:   2022-02-25T23:59:59+00:00
Accession:  0001104659-22-027293
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cellectar Biosciences names Chad Kolean CFO, promotes Jarrod Longcor to COO
---------------------------------------------------------------------------

- CFO Dov Elefant resigned Feb 22, 2022; Chad Kolean rejoined as CFO same day, previously served as CFO 2014-2017.
- Kolean receives $340K base salary, 40% target bonus, and 150,000-share option (3-yr vest) as inducement grant.
- Jarrod Longcor promoted to COO from Chief Business Officer; he has been with the company for 6 years.
- Option exercise price equals Feb 22, 2022 closing price; Kolean eligible for annual equity awards under 2021 plan.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1279704/000110465922027293/0001104659-22-027293-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1279704/000110465922027293/tm227716d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-027293

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer